Retraction note for a study that reported effects of novel calpain inhibitors in a transgenic Parkinson's disease/dementia with Lewy bodies animal model; the original findings have been withdrawn.

Although calpain inhibition is a biologically plausible neuroprotective avenue in PD, the retraction and lack of accessible data render this work unreliable and of minimal immediate value for therapeutic discovery.